Cardiac safety and clinical efficacy of high-dose domperidone for long-term treatment of gastroparesis symptoms

Kevin Woods, Mahesh Gajendran, Zorisadday Gonzalez, Marco Bustamante-Bernal, Irene Sarosiek, Karina Espino, Nathan Waterhouse, Tariq Siddiqui, Richard McCallum
DOI: 10.1136/jim-2021-001968 Published 22 June 2022
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

No eLetters have been published for this article.
Back to top
Email
Print
Alerts
Citation Tools
Cite This
Download PDF

Cardiac safety and clinical efficacy of high-dose domperidone for long-term treatment of gastroparesis symptoms
Kevin Woods, Mahesh Gajendran, Zorisadday Gonzalez, Marco Bustamante-Bernal, Irene Sarosiek, Karina Espino, Nathan Waterhouse, Tariq Siddiqui, Richard McCallum
Journal of Investigative Medicine Jun 2022, 70 (5) 1225-1232; DOI: 10.1136/jim-2021-001968
Reddit logo Twitter logo Facebook logo Mendeley logo
Respond to this article